The Oxford Science Park

Find Out The Latest

Keep in touch with news and developments from The Oxford Science Park and its occupiers here.

You can also follow us on LinkedIn

Immunocore Secures $130 Million Series B Financing

02 Mar 2020

Led by General Atlantic, funding will expand novel scientific platform and advance proprietary pipeline of ImmTAX™ molecules into the clinic (Oxfordshire, UK and Conshohocken, Pa. and Rockville, Md., US, 2 March 2020)Immunocore, a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune... Read more

Sumitomo Dainippon Pharma & Exscientia – New Drug Candidate Created Using AI begins Clinical Trial

30 Jan 2020

January 30, 2020 Sumitomo Dainippon Pharma Co., Ltd. Exscientia Ltd Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka, Japan, Representative Director, President and CEO: Hiroshi Nomura) and Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) announce that a phase I clinical study of... Read more

Bayer & Exscientia collaborate to leverage potential of AI in cardiovascular & oncology drug discovery

09 Jan 2020

Exscientia, the leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a collaboration with Bayer AG that aims to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. Under terms of the agreement, Exscientia will initially work on three projects with targets agreed between both parties. Exscientia may be eligible to receive up to €240 Million, including... Read more

Intuitive Announces New UK Headquarters in Oxford

04 Sep 2019

OXFORD, England–Intuitive (Nasdaq: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the opening of its United Kingdom and Republic of Ireland headquarters and training suite at Oxford Science Park’s Schrödinger Building. “Oxford is internationally renowned for medical and scientific innovation and we are proud to expand our collaboration with this community that we think... Read more

Blue Earth Diagnostics to be Acquired by Global Leader Bracco Imaging

27 Jun 2019

27th June 2019 ‒ Blue Earth Diagnostics to become a subsidiary of Bracco Imaging; retains name and management team ‒ ‒ Acquisition driven by lead product Axumin® (fluciclovine F 18), a novel molecular imaging agent for use with PET imaging to detect recurrent prostate cancer, and a robust pipeline ‒ ‒ Combined business will leverage Bracco’s diagnostic modalities, global competencies, portfolio and financial resources ‒ BURLINGTON,... Read more

News